Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands |
9 Months Ended |
Apr. 30, 2016 |
Apr. 30, 2015 |
| CASH FLOWS FROM OPERATING ACTIVITIES |
|
|
| Net Income |
$ 8,352
|
$ 6,302
|
| Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
| Depreciation and amortization |
8,991
|
8,955
|
| Amortization of investment net discount |
(6)
|
(1)
|
| Non-cash stock compensation expense |
962
|
866
|
| Excess tax benefits for share-based payments |
(68)
|
(68)
|
| Deferred income taxes |
280
|
431
|
| Provision for bad debts and cash discounts |
149
|
215
|
| Loss on the sale of fixed assets |
199
|
112
|
| Gain on sale of marketable securities |
0
|
(105)
|
| Life Insurance Benefits |
0
|
117
|
| (Increase) Decrease in assets: |
|
|
| Accounts receivable |
2,140
|
(1,183)
|
| Inventories |
(3,653)
|
198
|
| Prepaid expenses |
(593)
|
1,655
|
| Other assets |
(270)
|
(1,438)
|
| Increase (Decrease) in liabilities: |
|
|
| Accounts payable |
(1,383)
|
(691)
|
| Accrued expenses |
3,365
|
348
|
| Deferred compensation |
139
|
478
|
| Pension and postretirement benefits |
757
|
144
|
| Other liabilities |
48
|
167
|
| Total Adjustments |
11,057
|
9,966
|
| Net Cash Provided by Operating Activities |
19,409
|
16,268
|
| CASH FLOWS FROM INVESTING ACTIVITIES |
|
|
| Capital expenditures |
(7,052)
|
(13,945)
|
| Proceeds from sale of property, plant and equipment |
256
|
22
|
| Restricted cash |
0
|
129
|
| Purchases of short-term investments |
(26,977)
|
(700)
|
| Dispositions of short-term investments |
18,680
|
2,861
|
| Proceeds from sale of marketable securities |
0
|
108
|
| Proceeds from Life Insurance Policies |
0
|
903
|
| Net Cash Used in Investing Activities |
(15,093)
|
(10,622)
|
| CASH FLOWS FROM FINANCING ACTIVITIES |
|
|
| Principal payments on notes payable |
(3,484)
|
(3,500)
|
| Dividends paid |
(4,190)
|
(3,937)
|
| Purchase of treasury stock |
(18)
|
(122)
|
| Proceeds from issuance of treasury stock |
185
|
0
|
| Proceeds from issuance of common stock |
96
|
15
|
| Excess tax benefits for share-based payments |
68
|
68
|
| Net Cash Used in Financing Activities |
(7,343)
|
(7,476)
|
| Effect of exchange rate changes on cash and cash equivalents |
83
|
(21)
|
| Net Decrease in Cash and Cash Equivalents |
(2,944)
|
(1,851)
|
| Cash and Cash Equivalents, Beginning of Period |
20,138
|
16,230
|
| Cash and Cash Equivalents, End of Period |
17,194
|
14,379
|
| Supplemental disclosure of non-cash investing and financing activities: |
|
|
| Capital expenditures accrued, but not paid |
353
|
376
|
| Cash dividends declared and accrued, but not paid |
$ 1,407
|
$ 1,310
|